HCA Holdings Company Profile (NYSE:HCA)

HCA Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCA."

HCA Holdings, Inc. (NYSE:HCA) issued its earnings results on Tuesday, July, 25th. The company reported $1.75 EPS for the quarter, missing the consensus estimate of $1.80 by $0.05. The firm earned $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. HCA Holdings's revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.66 EPS. View HCA Holdings' Earnings History.

HCA Holdings issued an update on its FY17 earnings guidance on Tuesday, July, 25th. The company provided EPS guidance of $7.00-7.30 for the period, compared to the Thomson Reuters consensus estimate of $7.35. The company issued revenue guidance of $43.0-44.0 billion, compared to the consensus revenue estimate of $43.37 billion.

16 analysts have issued twelve-month target prices for HCA Holdings' shares. Their forecasts range from $81.00 to $103.00. On average, they expect HCA Holdings' stock price to reach $92.60 in the next year. View Analyst Ratings for HCA Holdings.

Here are some recent quotes from research analysts about HCA Holdings stock:

• 1. According to Zacks Investment Research, "HCA Healthcare’s   shares have outperformed the industry year to date. Its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. During the second quarter results the company reported earnings of  $1.77 per share which lagged estimates by 1.7% but were up 5.4% year over year. The earnings miss can be traced back to an increase in expenses, which outpaced revenue growth. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts  and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance." (8/8/2017)
• 2. Cantor Fitzgerald analysts commented, "CMS proposed a better than expected FY 18 hospital inpatient (IPPS) rate increase of 1.6% for operating payments and a total increase of 2.9%, including a new reimbursement methodology for uncompensated care. Although the impact of the new rates will vary among hospitals depending on patient mix and the level of uncompensated care, we expect better rates will help hospital stocks, which have been hurt by concern for the ACA. The proposed hospital IPPS rates were significantly higher than our 1% estimate (vs. 0.8%-2.3% over past five years)." (4/17/2017)

Some companies that are related to HCA Holdings include Fresenius Medical Care Corporation (FMS), Laboratory Corporation of America Holdings (LH), Quest Diagnostics Incorporated (DGX), DaVita HealthCare Partners (DVA), Universal Health Services (UHS), NMC Health PLC (NMC), HealthSouth Corporation (HLS), Acadia Healthcare Company (ACHC), Mednax (MD), Molina Healthcare (MOH), Chemed Corp. (CHE), Select Medical Holdings Corporation (SEM), LifePoint Health (LPNT), Udg Healthcare PLC (UDG), HMS Holdings Corp (HMSY), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO) and Community Health Systems (CYH).

HCA Holdings' management team includes the folowing people:

• R. Milton Johnson, Chairman of the Board, Chief Executive Officer
• Samuel N. Hazen, President, Chief Operating Officer
• William B. Rutherford, Chief Financial Officer, Executive Vice President
• Michael S. Cuffe M.D., President — Physician Services Group
• Jon Mark Foster, President - American Group
• Charles J. Hall, President - National Group
• Arnold Bruce Moore Jr., President - Service Line and Operations Integration
• Jonathan B. Perlin M.D., President - Clinical Services Group, Chief Medical Officer
• J. William B. Morrow, Senior Vice President - Finance, Treasurer
• Paul Martin Paslick, Senior Vice President, Chief Information Officer

HCA Holdings' stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (5.37%), Glenview Capital Management LLC (4.12%), State Street Corp (3.48%), Harris Associates L P (3.29%), Magellan Asset Management Ltd (2.68%) and Longview Partners Guernsey LTD (2.48%). Company insiders that own HCA Holdings stock include A Bruce Moore Jr, Alan R Yuspeh, Charles J Hall, Charles O Holliday Jr, Christopher F Wyatt, David Gwin Anderson, Henry R Kravis, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Joseph N Steakley, Juan Vallarino, Michael S Cuffe, P Martin Paslick, Ravi S Chari, Robert A Waterman, Sandra L Morgan, Thomas F Frist Jr and Victor L Campbell. View Institutional Ownership Trends for HCA Holdings.

HCA Holdings' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, UBS Asset Management Americas Inc., State Street Corp, AXA, Russell Investments Group Ltd., BB&T Securities LLC, Harris Associates L P and Canada Pension Plan Investment Board. Company insiders that have sold HCA Holdings stock in the last year include A Bruce Moore Jr, Charles J Hall, Christopher F Wyatt, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Michael S Cuffe, P Martin Paslick, Ravi S Chari, Robert A Waterman and Sandra L Morgan. View Insider Buying and Selling for HCA Holdings.

HCA Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Harbour Capital Advisors LLC, Northwestern Mutual Investment Management Company LLC, Parametric Portfolio Associates LLC, Arrowstreet Capital Limited Partnership, Victory Capital Management Inc., Longview Partners Guernsey LTD, Glenview Capital Management LLC and PGGM Investments. Company insiders that have bought HCA Holdings stock in the last two years include Charles O Holliday Jr and Thomas F Frist Jr. View Insider Buying and Selling for HCA Holdings.

Shares of HCA Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of HCA Holdings stock can currently be purchased for approximately $77.75.